The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies.
about
Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective Vitamins and Lifestyle (VITAL) studyReciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathologyPrediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling.Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPasesDissection of the transformation of primary human hematopoietic cells by the oncogene NUP98-HOXA9Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motifBone marrow fat: linking adipocyte-induced inflammation with skeletal metastasesThe modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemiaA Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.Spaceflight effects on T lymphocyte distribution, function and gene expression.Toll-like receptors and their role in carcinogenesis and anti-tumor treatment.Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study.Toll-Like Receptors (TLRs): The Role in Tumor Progression.Use of non-steroidal anti-inflammatory drugs and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis.Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.
P2860
Q24626410-1689D6CB-84ED-4582-90C5-B760C2918020Q26825075-FA25DED8-B07F-4938-85F7-F5E19BB50F39Q27902278-D33F9213-5D39-4528-AC1A-50787780E7D9Q28550876-D1A5ADC2-71FC-4F56-B8CF-7E1825BB606DQ33495581-2D514F54-17FD-4D8D-9BA2-6A9DB2F320A4Q33846983-A06F4670-DB96-4DF3-B958-ECE95785BB4AQ34132305-7C5EF180-A035-435F-A007-4A5C019BF73CQ34347558-00FE9554-12B6-4A51-A671-23EA9691067EQ35638851-35861CCB-6297-44A9-A6C5-6804AF02C246Q36194829-1BA2E42F-7CB4-43B4-B280-1F8D60B44E31Q36279606-98FA1971-FC3C-415D-AEF7-3952D887C469Q37086204-A694A932-2791-49F8-B91E-372B2019B088Q37354939-920FB6E7-E619-4EA7-AA73-ADB0A34C54D7Q37507892-CCF418AB-2ED9-457B-8938-F1FA404697DBQ38014847-06620B2D-DE1A-43B0-95D4-266AA111E761Q38262832-83EA7EDE-1E96-492D-9548-05D0761F2EE9Q47250120-87B44B95-6C33-4D23-87BC-CD90A6BCB28C
P2860
The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of non-steroidal anti ...... t of hematologic malignancies.
@en
The role of non-steroidal anti ...... t of hematologic malignancies.
@nl
type
label
The role of non-steroidal anti ...... t of hematologic malignancies.
@en
The role of non-steroidal anti ...... t of hematologic malignancies.
@nl
prefLabel
The role of non-steroidal anti ...... t of hematologic malignancies.
@en
The role of non-steroidal anti ...... t of hematologic malignancies.
@nl
P2093
P2860
P1433
P1476
The role of non-steroidal anti ...... t of hematologic malignancies.
@en
P2093
Pawel Robak
Piotr Smolewski
Tadeusz Robak
P2860
P304
P356
10.1080/10428190802108854
P577
2008-08-01T00:00:00Z